Previous 10 | Next 10 |
Image source: The Motley Fool. Hologic Inc (NASDAQ: HOLX) Q3 2020 Earnings Call Jul 29, 2020 , 4:30 p.m. ET Operator Continue reading
Hologic, Inc. (HOLX) Q3 2020 Results Conference Call July 29, 2020 04:30 PM ET Company Participants Mike Watts - VP, IR and Corporate Communications Steve MacMillan - Chairman, President and CEO Karleen Oberton - CFO Conference Call Participants Patrick Donnelly - Citi. C...
Hologic (NASDAQ: HOLX ) fiscal Q3 results : More news on: Hologic, Inc., Healthcare stocks news, Earnings news and commentary, , Stocks on the move, Read more ...
Hologic (NASDAQ: HOLX ) : Q3 Non-GAAP EPS of $0.75 beats by $0.37 ; GAAP EPS of $0.53 beats by $0.37 . More news on: Hologic, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
— Revenue of $822.9 Million Declines 3.5% due to Cynosure Divestiture, 3.1% in Constant Currency — — Organic Revenue Increases 7.7%, 8.1% in Constant Currency, as Strong Sales of COVID Tests Offset Declines in Other Businesses — — Company Posts GAAP D...
NetworkNewsWire Editorial Coverage : Effective pandemic response relies first and foremost on fast and accurate testing to buy time and save lives while therapeutics and vaccines are developed. Coronavirus cases continued to surge in the US this month, showing no signs of slowing since lock...
Source : ClearBridge Investments Editor's Note : The summary bullets for this article were chosen by Read more ...
July 13, 2020 FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – July 13, 2020 – Coronavirus cases continue to rise in the US this month as regulations lift, causing overambitious governors in several states to backpedal on previous cl...
Hologic ( HOLX -0.5% ) announces the U.S. commercial launch of its SuperSonic MACH 40 cart-based ultrasound system. More news on: Hologic, Inc., Healthcare stocks news, Read more ...
Hologic ( HOLX +0.1% ) is up modestly on below-average volume on the heels of the publication of performance characteristics of its SARS-CoV-2 molecular test performed on its automated Panther system. More news on: Hologic, Inc., Healthcare stocks news, Stocks on the move, Read mor...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 10:30:04 ET BTIG analyst issues NEUTRAL recommendation for HOLX on July 30, 2024 08:28AM ET. The previous analyst recommendation was Neutral. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current an...
2024-07-30 09:30:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for HOLX on July 30, 2024 07:43AM ET. The previous analyst recommendation was Sector Perform. HOLX was trading at $79.64 at issue of the analyst recommendation. The overall analyst consensus ...
– Revenue of $1,011.4 Million, GAAP Diluted EPS of $0.82, and Non-GAAP Diluted EPS of $1.06; All Met or Exceeded Guidance – – Total Company Revenue Growth of 2.7%, or 3.1% in Constant Currency and 5.8% Organically excluding COVID-19; Against Growth of 18.4% in the Prior Y...